Delivery Order SPE2DB22D2007-SPE2DB25FJ3LU
Award Date 7/30/25
Potential Completion Date 8/20/25
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,288.86 to AmerisourceBergen Drug Corp for 100 tablets of Envarsus XR 1 mg, a pharmaceutical product used in transplant immunosuppression therapy. The contract, awarded on August 27, 2025, with an ultimate completion date of September 18, 2025, utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award through open procurement. Performance will occur at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $1,288.86 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for 100 tablets of Envarsus XR 1 mg, a pharmaceutical product used in transplant immunosuppression therapy. This firm fixed price contract with an ultimate completion date of September 17, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a delivery order valued at $1,718.48 to AmerisourceBergen Drug Corp for 100 tablets of Envarsus XR 1 mg on August 4, 2025, with an ultimate completion date of August 25, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,711.95 to AmerisourceBergen Drug Corp for 100 tablets of Envarsus XR 4 mg on August 4, 2025, with an ultimate completion date of August 25, 2025. This firm fixed price, non-set-aside contract represents a pharmaceutical supply delivery executed under a competitively awarded vehicle. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,288.86 to AmerisourceBergen Drug Corp for Envarsus XR 1 mg tablets (100 count), with an ultimate completion date of August 20, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded and represents a continuation of the contractor's pharmaceutical supply activities supporting federal medical procurement. The work will be performed at AmerisourceBergen Drug Corp's corporate office location in...
- The Defense Logistics Agency awarded a $1,288.86 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Envarsus XR 1 mg on July 16, 2025, with completion targeted for August 6, 2025. This non-competitive, non-set-aside award was issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The product will be delivered to...
- The Defense Logistics Agency (DLA) awarded a $1,711.95 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Envarsus XR 4 mg on July 31, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order for pharmaceutical supply to support federal medical procurement needs. The contract was executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $3,436.96 to AmerisourceBergen Drug Corp for 100 tablets of Envarsus XR 1 mg on June 11, 2025, with a completion date of July 3, 2025. This firm fixed price, non-set-aside contract is being performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. This delivery order falls under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,577.72 for Envarsus XR 1 mg tablets (100-count) on September 12, 2025, with an ultimate completion date of October 3, 2025. The contract is structured as firm fixed price with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under the...
- The Defense Logistics Agency awarded a $3,423.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Envarsus XR 4 mg, a pharmaceutical product used in immunosuppressive therapy. The contract, which became effective on September 9, 2025, with an ultimate completion date of September 30, 2025, represents a non-competitive, non-set-aside award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order...